TRPV1 and asthma: TRPV1/TRPA1-mediated mechanisms tie tear gas injury to pathways involved in acute/chronic pain, cough, asthma, dermatitis, and neurodegeneration; animal models suggest transient receptor potential inhibitors as potential countermeasures [16], [18].